Barefoot Training for Health & Longevity - Quick Reference Sheet

Barefoot Training for Health & Longevity

Created on 10/09/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Barefoot training, a practice of walking, running, or balancing barefoot or in thin, flexible shoes, aims to strengthen foot muscles that supportive shoes leave underused. Several trials show modest foot-strength gains; most found no balance gain, and none tested falls. Quick switches often cause calf, shin, and Achilles soreness; even gradual ones can stress forefoot bones. It is unsuitable for people with diabetes-related loss of foot sensation. (Full Review)

Protocol

Minimalist-shoe walking (Gabriel et al.)
About 3,000 steps per day, then 5,000
3,000 steps per day in week 1, then 5,000 steps per day for weeks 2 to 4
Running transition (Lindlein et al., Hamburg)
+5% of weekly distance per week
Minimalist running increased by 5% of individual weekly distance per week over 8 weeks
Running volume ceiling (Fuller et al.)
Under 35 km per week
In minimalist shoes
Time to effect
Foot muscles
4 to 8 weeks
Some foot muscles grew by week 4; strength rose by week 8
Balance
Within 4 weeks
Improved with minimalist-shoe walking
Bone and tendon adaptation
Months
Adaptation to new forefoot loading

Benefits

Contraindications
  • Diabetes with loss of protective sensation (10-g monofilament testing)
  • Active foot ulcer
  • Open foot wounds or recent foot surgery (theoretical)
  • Current or recent foot bone stress injury (theoretical)
  • Severe peripheral artery disease (theoretical)
  • Older adults with recurrent falls (unsupervised barefoot or sock walking)
  • Runners with body mass of 85.7 kg or more (running in minimalist shoes)
  • Nerve-damaging drugs (paclitaxel, vincristine; long-term metronidazole): avoid barefoot outdoor use (theoretical)
Key Interactions
  • Fluoroquinolone antibiotics (ofloxacin, norfloxacin, ciprofloxacin): caution (theoretical)
  • Systemic glucocorticoids (prednisone, dexamethasone): caution (theoretical)
  • Anticoagulants (warfarin, apixaban, rivaroxaban): monitor (theoretical)
  • Sedative-hypnotics (zolpidem, lorazepam): caution (theoretical)
  • Over-the-counter pain relievers (NSAIDs; ibuprofen, naproxen): caution (theoretical)
  • Over-the-counter sedating antihistamines (diphenhydramine, doxylamine): caution (theoretical)
  • Vitamin D and calcium supplements: monitor (theoretical)
  • Supplements with additive effects (creatine, protein): no caution needed (theoretical)
  • Foot-strengthening exercises: no added strength; no caution needed
  • Arch supports and orthotics: caution, opposing effect (theoretical)
  • Running gait retraining (forefoot landing, quicker steps): monitor (theoretical)

Risk & Side Effects

  • High: Calf, shin, and Achilles pain during transition
  • Medium: Sole wounds and soil-borne infections
  • Low: Falls when barefoot at home in older adults; overuse injury during transition; foot ulcers in people with diabetic neuropathy
  • Speculative:

Monitoring

Marker Target Why
Protective sole sensation (10-g monofilament test) Sensation felt at all tested sites Safety check: loss stops barefoot use
Toe-flexor strength (handheld or plate dynamometer) No established target; track change from own baseline Expected to change: rises with training

Cadence: Daily sole inspection during the first 3 months; strength and balance retesting at 4 and 8 weeks, then every 6 to 12 months; sensation testing yearly with diabetes, or sooner if numbness appears; weekly pain ratings during any running transition

Qualitative Assessment

  • Single-leg stance time compared with own baseline
  • Foot and calf soreness, rated weekly during transitions
  • Comfort walking on uneven ground
  • Skin condition of the soles (calluses, cuts, cracks)
  • Confidence and steadiness when walking without shoes